DIABETES IN NOD MICE DOES NOT REQUIRE LYMPHOCYTES-T EXPRESSING V-BETA-8 OR V-BETA-5

被引:19
作者
MCDUFFIE, M
机构
[1] UNIV COLORADO,HLTH SCI CTR,BARBARA DAVIS CTR CHILDHOOD DIABET,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT,DENVER,CO 80262
关键词
D O I
10.2337/diabetes.40.11.1555
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of destructive pancreatic infiltrates and overt diabetes in animal models of insulin-dependent (type I) diabetes mellitus can be greatly reduced by inactivating or eliminating most T lymphocytes early in life. Because of theoretical and practical concerns about inducing long-term pan-T-lymphocyte inactivation for prevention or treatment of type I diabetes in humans, we hoped that more selective suppression of only the diabetogenic T lymphocyte population might be possible. To this end, two groups suggested that diabetogenic subpopulations of T lymphocytes in NOD mice could be identified by the protein sequence of their T-lymphocyte receptors. This assertion was based on experimental elimination of candidate T-lymphocyte subpopulations in two different short-term models of diabetes induction in NOD mice. For these experiments, identification and elimination of T-lymphocyte subsets were accomplished with monoclonal antibodies that bind specifically to the variable region of the beta-chain (V-beta) of the T-lymphocyte antigen receptor and divide the T-lymphocyte pool of the NOD mouse into approximately 20 V-beta-subsets. To test the relationship between the two T-lymphocyte V-beta-subsets implicated in these studies and pancreatic beta-cell destruction in unmanipulated animals, both T-lymphocyte subpopulations identified were genetically eliminated from NOD-derived mice by introduction of a mutant T-lymphocyte receptor V-beta-gene, from which these sequences are genomically deleted. Histological evidence of severe beta-cell destruction and overt diabetes was found in mice homozygous for the deleted V-beta-gene, indicating that neither V-beta-gene segment identified in previous studies is required for diabetogenesis in unmanipulated diabetes-prone mice.
引用
收藏
页码:1555 / 1559
页数:5
相关论文
共 17 条
[11]   PREVENTIVE EFFECTS OF CYCLOSPORINE ON DIABETES IN NOD MICE [J].
MORI, Y ;
SUKO, M ;
OKUDAIRA, H ;
MATSUBA, I ;
TSURUOKA, A ;
SASAKI, A ;
YOKOYAMA, H ;
TANASE, T ;
SHIDA, T ;
NISHIMURA, M ;
TERADA, E ;
IKEDA, Y .
DIABETOLOGIA, 1986, 29 (04) :244-247
[12]   T-CELL RECEPTOR V-GENE USAGE OF ISLET BETA-CELL REACTIVE T-CELLS IS NOT RESTRICTED IN NONOBESE DIABETIC MICE [J].
NAKANO, N ;
KIKUTANI, H ;
NISHIMOTO, H ;
KISHIMOTO, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1091-1097
[13]   LYMPHOCYTE VACCINATION AGAINST EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS - EVALUATION OF VACCINATION PROTOCOLS [J].
OFFNER, H ;
JONES, R ;
CELNIK, B ;
VANDENBARK, AA .
JOURNAL OF NEUROIMMUNOLOGY, 1989, 21 (01) :13-22
[14]   AN EXPLANATION FOR THE PROTECTIVE EFFECT OF THE MHC CLASS-II I-E MOLECULE IN MURINE DIABETES [J].
REICH, EP ;
SHERWIN, RS ;
KANAGAWA, O ;
JANEWAY, CA .
NATURE, 1989, 341 (6240) :326-328
[15]   IMMUNOTHERAPY OF THE NONOBESE DIABETIC MOUSE - TREATMENT WITH AN ANTIBODY TO T-HELPER LYMPHOCYTES [J].
SHIZURU, JA ;
TAYLOREDWARDS, C ;
BANKS, BA ;
GREGORY, AK ;
FATHMAN, CG .
SCIENCE, 1988, 240 (4852) :659-662
[16]   IMMUNIZATION WITH A SYNTHETIC T-CELL RECEPTOR V-REGION PEPTIDE PROTECTS AGAINST EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS [J].
VANDENBARK, AA ;
HASHIM, G ;
OFFNER, H .
NATURE, 1989, 341 (6242) :541-544
[17]   PREDOMINANT EXPRESSION OF A T-CELL RECEPTOR V-BETA GENE SUBFAMILY IN AUTOIMMUNE ENCEPHALOMYELITIS [J].
ZAMVIL, SS ;
MITCHELL, DJ ;
LEE, NE ;
MOORE, AC ;
WALDOR, MK ;
SAKAI, K ;
ROTHBARD, JB ;
MCDEVITT, HO ;
STEINMAN, L ;
ACHAORBEA, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (05) :1586-1596